𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Characterization of E2F3a function in HepG2 liver cancer cells

✍ Scribed by Wei Li; Guo-Xin Ni; Ping Zhang; Zheng-Xi Zhang; Wei Li; Qiang Wu

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
499 KB
Volume
111
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

E2F3a is a transcription factor that has been shown to be overexpressed in liver cancer tissues. To characterize the function of E2F3a in hepatocellular carcinoma (HCC), effects of ectopic overexpression of E2F3a on cell cycle, apoptosis, and gene expression of HepG2 cells were studied. E2F3a significantly enhances the apoptotic rate of HepG2 cells by 33% but only has minor effects on cell proliferation. By using microarray analyses, we identified 162 target genes (160 upregulated and 2 downregulated) of the E2F3a. Differential expression of 11 genes was further confirmed by real‐time PCR. Eight of these 11 genes, including XAF1, CEACAM1, STAT1, ATF3, TNFSF10, KLF6, CLDN1, and TAP1, were confirmed to be upregulated by more than twofold. Functional enrichments of differentially expressed genes retrieved 21 apoptosis‐related genes and 32 transcriptional regulation‐related genes. These results suggest that E2F3a induces apoptosis in HepG2 cells and plays important roles in regulating transcription. Finally, positive correlation was found between E2F3a and CEACAM1 mRNA levels in clinically well‐differentiated human HCC specimens. J. Cell. Biochem. 111: 1244–1251, 2010. © 2010 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Improvement of HepG2/C3a cell functions
Improvement of HepG2/C3a cell functions in a microfluidic biochip
✍ Jean Matthieu Prot; Caroline Aninat; Laurent Griscom; Florence Razan; Céline Bro 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 740 KB

## Abstract Current developments in tissue engineering and microtechnology fields allow the use of microfluidic biochip as microtools for in vitro investigations. In the present study, we describe the behavior of HepG2/C3a cells cultivated in a poly(dimethylsiloxane) (PDMS) microfluidic biochip cou

Molecular and functional characterizatio
Molecular and functional characterization of bile acid transport in human hepatoblastoma HepG2 cells
✍ G A Kullak-Ublick; U Beuers; G Paumgartner 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 603 KB

Bile acids are taken up into human liver by Na+-dependent and Na+-independent transport mechanisms. In hepatocarcinogenesis, numerous liver-specific functions are lost and the uptake of organic anions is markedly reduced. We have investigated the molecular and functional derangements of bile acid tr

Characterization of liver function in tr
Characterization of liver function in transdifferentiated hepatocytes
✍ Zoë D. Burke; Chia-Ning Shen; Kate L. Ralphs; David Tosh 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 999 KB

## Abstract We previously demonstrated that dexamethasone (Dex) induces the transdifferentiation (or conversion) of the pancreatic progenitor cell line AR42J‐B13 (B13) to hepatocytes based on the expression of liver proteins. We have extended our original observations to determine: (1) the effects

Functional characterization of a novel F
Functional characterization of a novel FGFR2 mutation, E731K, in craniosynostosis
✍ Jounghyen Park; Ok-Jin Park; Won-Joon Yoon; Hyun-Jung Kim; Kang-Young Choi; Tae- 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 305 KB

## Abstract Craniosynostosis is a condition in which some or all of the sutures in the skull of an infant close prematurely. Fibroblast growth factor receptor 2 (FGFR2) mutations are a well‐known cause of craniosynostosis. Many syndromes that comprise craniosynostosis, such as Apert syndrome, Crouz

PI3K signaling maintains c-myc expressio
PI3K signaling maintains c-myc expression to regulate transcription of E2F1 in pancreatic cancer cells
✍ Carolin Schild; Matthias Wirth; Maximilian Reichert; Roland M. Schmid; Dieter Sa 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 339 KB

## Abstract Phosphatidylinositol 3‐kinase (PI3K) signaling controls survival and proliferation of cancer cells and is activated in around 60% of pancreatic ductal adenocarcinomas (PDACs). Although not entirely clarified, PI3K signaling is linked to cell cycle progression of PDAC cells. In this stud